This topic contains a solution. Click here to go to the answer

Author Question: Trintech offers ________ services. (a) online credit-card transaction. (b) e-wallet. (c) ... (Read 34 times)

Marty

  • Hero Member
  • *****
  • Posts: 553
Trintech offers ________ services.
 
  (a) online credit-card transaction.
  (b) e-wallet.
  (c) digital cash.
  (d) bill payment.

Question 2

POS is an acronym for:
 
  (a) point-of-sale.
  (b) payment-of-sale.
  (c) path-of-sale.
  (d) payment-on-security.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bob

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

Ans: (a)

Answer to Question 2

Ans: (a)




Marty

  • Member
  • Posts: 553
Reply 2 on: Jul 7, 2018
Thanks for the timely response, appreciate it


olderstudent

  • Member
  • Posts: 339
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

To prove that stomach ulcers were caused by bacteria and not by stress, a researcher consumed an entire laboratory beaker full of bacterial culture. After this, he did indeed develop stomach ulcers, and won the Nobel Prize for his discovery.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library